Future studies should perform experiments in animal models to validate the role of RGS2 in glucose tolerance and insulin sensitivity to demonstrate the value of targeting RGS2 in the treatment and prevention of T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.